Stay Alert for Safety Concerns With Picato for Actinic Keratosis

Health Canada is warning about an increased risk of skin cancer in patients using Picato gel (ingenol mebutate) for actinic keratosis.

These thick, hard, and scaly skin patches from chronic sun exposure can progress to squamous cell carcinoma.

The new warning is based on numerous clinical trials and case reports linking the use of Picato with skin cancer.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote